rxstatShortages › Hydrocortisone Zinc

Hydrocortisone Zinc shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Hydrocortisone Zinc products are in shortage in Canada (1 of 5 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
1 / 5
In shortage since
Apr 11, 2014
Reports on file
14
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
RIVASOL-HC SUPPOSITORIES
10MG 10MG · SUPPOSITORY · LABORATOIRE RIVA INC
DIN 02240112 · since Apr 11, 2014, no end estimate · Disruption of the manufacture of the drug.
Resolved
ANUSOL-HC OINTMENT
0.5% 0.5% · OINTMENT · CHURCH & DWIGHT CANADA CORP
DIN 00505773 · ended Feb 27, 2026 · Shortage of an inactive ingredient or component.
Resolved
ANUSOL-HC SUPPOSITORIES
10MG 10MG · SUPPOSITORY · CHURCH & DWIGHT CANADA CORP
DIN 00476285 · ended Jun 2, 2025 · Disruption of the manufacture of the drug.
Resolved
ANUSOL-HC OINTMENT
0.5% 0.5% · OINTMENT · CHURCH & DWIGHT CANADA CORP
DIN 00505773 · ended Sep 13, 2023 · Demand increase for the drug.
Resolved
ANUSOL-HC OINTMENT
0.5% 0.5% · OINTMENT · CHURCH & DWIGHT CANADA CORP
DIN 00505773 · ended Jul 13, 2023 · Disruption of the manufacture of the drug.
Resolved
ANUSOL-HC SUPPOSITORIES
10MG 10MG · SUPPOSITORY · CHURCH & DWIGHT CANADA CORP
DIN 00476285 · ended May 19, 2022 · Demand increase for the drug.
Resolved
ANUSOL-HC OINTMENT
0.5% 0.5% · OINTMENT · CHURCH & DWIGHT CANADA CORP
DIN 00505773 · ended Apr 26, 2022 · Demand increase for the drug.
Resolved
ANUSOL-HC OINTMENT
0.5% 0.5% · OINTMENT · CHURCH & DWIGHT CANADA CORP
DIN 00505773 · ended Mar 4, 2022 · Disruption of the manufacture of the drug.
Resolved
ANUSOL-HC SUPPOSITORIES
10MG 10MG · SUPPOSITORY · CHURCH & DWIGHT CANADA CORP
DIN 00476285 · ended Mar 4, 2022 · Disruption of the manufacture of the drug.
Discontinued
EGOZINC-HC
0.5% 0.5% · OINTMENT · PHARMASCIENCE INC
DIN 02209764
Resolved
ANUSOL-HC SUPPOSITORIES
10MG 10MG · SUPPOSITORY · CHURCH & DWIGHT CANADA CORP
DIN 00476285 · ended Oct 8, 2021 · Shortage of an inactive ingredient or component.
Resolved
EGOZINC-HC
0.5% 0.5% · OINTMENT · PHARMASCIENCE INC
DIN 02209764 · ended Jun 5, 2020 · Shortage of an inactive ingredient or component.

Showing 12 of 14 reports. All reports are on file with Health Canada.

What's happening

Hydrocortisone Zinc is currently affected by an active shortage report filed with Health Canada by LABORATOIRE RIVA INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Hydrocortisone Zinc is classified under “AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE” (ATC C05AA).

Recent changes

Common questions

When will Hydrocortisone Zinc be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Hydrocortisone Zinc in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (agents for treatment of hemorrhoids and anal fissures for topical use)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.